Awarded without open competition
Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.
Key facts
- Buyer
- NHS Greater Glasgow and Clyde · Body governed by public law
- Supplier
- Labsystems Diagnostics OY SME
- Value
- £237,847
- Procedure
- Award procedure without prior publication of a call for competition
- Sector
- Medical equipment & pharmaceuticals · Laboratory reagents (CPV 33696500)
- Region
- Scotland
- Official notice
- 031045-2026 on Find a Tender
- Timeline
-
- Contract date5 Mar 2026
- Published2 Apr 2026Published 28 days after the contract date
Description
The Scottish Newborn Screening Laboratory has been commissioned to participate in the in service evaluation for Spinal Muscular Atrophy (SMA) organised by the National Screening Committee. NHSGG&C require newborn screening kits that measure both SMN1 and SMN2 genes simultaneously. The SMN2 copy number must be screened for at the same time as the SMN1 deletion in keeping with the Scottish screening protocol. The requirement to screen died blood spot samples from newborn babies for Spinal Muscular Atrophy (SMA). Scotland has begun a 2 year evaluation of SMA screening on behalf of the National Screening Committee to gather data to allow a decision to be made about if SMA screening should be included in the UK Newborn Screening Panel. SMA is cause by a deletion of the SMN1 gene, but the severity of the disease depends on another gene called SMN2. SMN2 is present in all babies in various copy numbers, and the lower the copy number the more severe the disease.
About the supplier
Labsystems Diagnostics OY: every public contract they have won.